Nathan J Dowden Entrada Therapeutics, Inc. (TRDA) insider trading activity

Nathan J Dowden is President & COO of Entrada Therapeutics, Inc.. Currently has a direct ownership of 179,059 shares of TRDA, which is worth approximately $1.52 Million. The most recent transaction as insider was on Oct 25, 2022, when has been sold 9,348 shares (Common Stock) at a price of $20.97 per share, resulting in proceeds of $196,028. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 179K

0% 3M change

43.08% 12M change

Total Value Held $1.52 Million

Nathan J Dowden Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 25 2022	SELL Open market or private sale	$196,028 $20.97 p/Share	9,348 Reduced 16.48%	47,383 Common Stock
Oct 24 2022	SELL Open market or private sale	$46,325 $19.27 p/Share	2,404 Reduced 4.07%	56,731 Common Stock
Oct 21 2022	SELL Open market or private sale	$50,682 $18.29 p/Share	2,771 Reduced 4.48%	59,135 Common Stock
Oct 20 2022	SELL Open market or private sale	$16,353 $18.07 p/Share	905 Reduced 1.44%	61,906 Common Stock
Sep 26 2022	SELL Open market or private sale	$24,380 $15.79 p/Share	1,544 Reduced 2.4%	62,811 Common Stock
Sep 23 2022	SELL Open market or private sale	$15,341 $15.07 p/Share	1,018 Reduced 1.56%	64,355 Common Stock
Sep 21 2022	SELL Open market or private sale	$49,551 $15.13 p/Share	3,275 Reduced 4.77%	65,373 Common Stock

Sep 15 2022	SELL Open market or private sale	$1,501 $15.01 p/Share	100 Reduced 0.15%	68,648 Common Stock
Sep 09 2022	SELL Open market or private sale	$13,027 $15.06 p/Share	865 Reduced 1.24%	68,748 Common Stock
Sep 08 2022	SELL Open market or private sale	$13,817 $15.15 p/Share	912 Reduced 1.29%	69,613 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	-	5,632 Added 7.4%	70,525 Common Stock
Jun 27 2022	SELL Open market or private sale	$100,282 $13.0 p/Share	7,714 Reduced 10.62%	64,893 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	11,263 Added 13.43%	72,607 Common Stock

NJD

Nathan J Dowden

President & COO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Value

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA

Account